topics / serm
Tagged serm.
- Strong human Clomiphene (Clomid) Clomiphene is a selective estrogen receptor modulator (SERM), not a peptide, with strong human evidence that it raises testosterone in hypogonadal men while preserving fertility; male use is off-label, it is prescription-only, and it is banned in sport at all times.
- Preliminary human Enclomiphene Enclomiphene is the anti-estrogenic isomer of clomiphene — a selective estrogen receptor modulator (SERM), not a peptide. Human trials consistently show it raises testosterone while preserving fertility, but it is NOT FDA-approved for any use, is available only via off-label compounding, and is banned in sport at all times.
- Strong human Raloxifene (Evista) Raloxifene is a selective estrogen receptor modulator (SERM) — an FDA-approved postmenopausal osteoporosis and breast-cancer-risk-reduction drug, not a peptide. Its defining serious risks are blood clots and fatal stroke; it is banned in sport at all times (WADA S4.2).
- Strong human Tamoxifen (Nolvadex) Tamoxifen is a selective estrogen receptor modulator (SERM) — an FDA-approved breast-cancer drug with one of the strongest evidence bases in oncology, not a peptide. Anabolic-steroid users take it off-label to blunt gynecomastia and attempt testosterone 'restart,' an unstudied practice that is banned in sport (WADA S4.2) and not without real risk.